Market Outlook Snapshot Market Dynamics Regional Forecast Country Insights Segment Analysis Competitive Landscape Industry News report.faq_name
On This Report

Healthcare Humanoid Robot Market Size & Forecasts 2026-2035, By Segments (Component, Application, End-use), Growth Opportunities, Innovation Landscape, Regulatory Shifts, Strategic Regional Insights (U.S., Japan, China, South Korea, UK, Germany, France), and Competitive Dynamics (SoftBank Robotics, Hanson Robotics, UBTech, Toyota, Engineered Arts)

Report ID: FBI 20047| Published Date: Dec-2025| Format: PDF, Excel
MARKET OUTLOOK

Market Size and Growoth Outlook

Healthcare Humanoid Robot Market size is expected to advance from USD 2.61 billion in 2025 to USD 12.87 billion by 2035, registering a CAGR of more than 17.3% across 2026-2035. By 2026, the industry is anticipated to generate USD 3.02 billion in revenue.

Base Year Value (2025)
USD 2.61 Billion
CAGR (2026-2035)
17.3%
Forecast Year Value (2035)
USD 12.87 Billion
Historical Data Period
2022-2025
Largest Region
North America
Forecast Period
2026-2035

Get more details on this report

Request Free Sample Report
SNAPSHOT

Healthcare Humanoid Robot Market Intelligence Snapshot

Regional Market Dynamics

Segment Momentum

Market Expansion Drivers

Leading Market Participants

FORECAST SNAPSHOT

Global Market Forecast Snapshot

Market Outlook

Regional and Segment Outlook

MARKET DYNAMICS

Market Growth Drivers and Industry Trends

Aging Population & Labor Shortages in Care

The healthcare humanoid robot market is significantly influenced by the aging population and concurrent labor shortages in the caregiving sector. As the global population ages, the demand for healthcare services escalates, creating a pressing need for innovative solutions to supplement human caregivers. The World Health Organization has highlighted that by 2050, the number of people aged 60 years and older will outnumber children under five, intensifying the strain on healthcare systems. This demographic shift not only elevates the necessity for humanoid robots to assist in routine tasks but also creates strategic opportunities for established companies like SoftBank Robotics, which has developed robots like Pepper to engage with elderly patients. New entrants can capitalize on this trend by developing tailored solutions that address specific needs within this demographic, such as companionship and mobility assistance.

Advanced Robotics in Hospital Support

The integration of advanced robotics in hospital support is reshaping the healthcare humanoid robot market. Hospitals are increasingly adopting robotic systems for tasks ranging from surgical assistance to patient management, enhancing operational efficiency and improving patient outcomes. According to the American College of Surgeons, robotic-assisted surgeries have seen a significant uptick, demonstrating the effectiveness of these technologies in complex procedures. This trend not only streamlines hospital workflows but also reduces the burden on healthcare staff, allowing them to focus on more critical care activities. Established players like Intuitive Surgical are leveraging these advancements, while new entrants can explore niche applications, such as robotic rehabilitation systems, to meet the evolving demands of healthcare facilities.

Social Acceptance & Regulatory Pathways

Social acceptance and evolving regulatory pathways are pivotal in shaping the healthcare humanoid robot market. As societal attitudes toward robotics in healthcare shift, acceptance of humanoid robots as companions and assistants is growing. The European Union's initiatives to establish regulatory frameworks for medical robots highlight the importance of safety and efficacy, paving the way for wider adoption. This regulatory clarity not only reassures consumers but also encourages investment in research and development. Companies like Boston Dynamics are actively engaging with regulatory bodies to ensure compliance while innovating their offerings. For both established firms and startups, the opportunity lies in aligning product development with regulatory standards, ensuring that innovations are not only accepted by society but also meet stringent safety requirements, thus facilitating smoother market entry.

Industry Restraints:

High Development Costs

The healthcare humanoid robot market is significantly restrained by the high development costs associated with advanced robotics technology. Creating humanoid robots that can effectively assist in healthcare settings requires substantial investment in research and development, sophisticated engineering, and ongoing maintenance. For instance, a report from the International Federation of Robotics highlights that the initial costs of deploying humanoid robots can exceed millions of dollars, making it challenging for healthcare facilities, particularly smaller ones, to justify the expenditure. This financial barrier not only limits the adoption of such technologies but also creates a hesitancy among potential investors and stakeholders who may perceive the risks as outweighing the potential benefits. Consequently, established companies may focus on incremental innovations rather than groundbreaking advancements, while new entrants struggle to secure funding in a competitive landscape that favors well-established players.

Integration Challenges with Existing Systems

Another critical restraint is the integration challenges faced when implementing humanoid robots within existing healthcare infrastructures. Many healthcare facilities operate on legacy systems that are not designed to accommodate advanced robotic technologies, leading to operational inefficiencies and increased training requirements. According to a study by the Healthcare Information and Management Systems Society, the lack of interoperability between robotic systems and existing electronic health records can hinder effective collaboration among healthcare providers. This not only complicates workflows but also raises concerns about patient safety and data security. For market participants, these integration hurdles can result in significant delays and added costs, ultimately impacting their ability to deliver timely care. As the market evolves, addressing these integration issues will be crucial for fostering broader acceptance and facilitating smoother transitions to robotic solutions in healthcare settings.

Growth Driver Impact on CAGR Regulatory Influence Geographic Relevance Adoption Rate Impact Timeline
Aging population & labor shortages in care 2.40% Short term (≤ 2 yrs) Japan, Europe (spillover: North America) Medium Fast
Advanced robotics in hospital support 2.20% Medium term (2–5 yrs) North America, Asia Pacific (spillover: Europe) Medium Moderate
Social acceptance & regulatory pathways 1.90% Long term (5+ yrs) Europe, North America (spillover: Asia Pacific) High Moderate
CUSTOM RESEARCH

Unlock insights tailored to your business with our bespoke market research solutions.

Click to get your customized report now.

Request Customization →
REGIONAL FORECAST

Regional Demand Dynamics

Polymer Modified Bitumen Market
Largest Region
North America
39.9% Market Share in 2025

North America Market Statistics:

North America represented more than 39.9% of the global healthcare humanoid robot market in 2025, establishing itself as the largest and fastest-growing region in this sector. This leadership is primarily driven by advanced healthcare infrastructure and substantial investments in research and development, which foster innovation and adoption of humanoid robots in healthcare settings. The region's robust demand for automation in healthcare, coupled with shifting consumer preferences towards technology-driven solutions, has catalyzed a transformative landscape. For instance, the American Medical Association has highlighted the increasing integration of robotics in patient care, emphasizing the need for efficiency and enhanced patient outcomes. As digital transformation accelerates and economic resilience strengthens, North America is poised to offer significant opportunities for stakeholders in the healthcare humanoid robot market.

The United States anchors the North American market for healthcare humanoid robots, leveraging its advanced healthcare infrastructure to drive adoption. The unique interplay of regulatory support and competitive strategies among leading firms, such as Intuitive Surgical and Boston Dynamics, has created a fertile ground for innovation. The U.S. Food and Drug Administration's streamlined approval processes for robotic technologies have further accelerated market entry, enabling companies to meet the rising consumer demand for robotic assistance in surgical procedures and elder care. This environment not only enhances patient care but also positions the U.S. as a key player in shaping the future of healthcare robotics. The strategic implications of these dynamics indicate that the U.S. will continue to lead the North American market, reinforcing the region's overall growth in the healthcare humanoid robot sector.

Asia Pacific Market Analysis:

Asia Pacific has emerged as the fastest-growing region in the healthcare humanoid robot market, registering rapid growth with a CAGR of 20.2%. This remarkable expansion is primarily driven by a rising aging population coupled with accelerated technology adoption across the region. The increasing prevalence of chronic diseases and the need for efficient healthcare solutions are prompting healthcare providers to explore innovative robotic technologies. As nations within this region prioritize healthcare efficiency, the deployment of humanoid robots is seen as a viable solution to address labor shortages and enhance patient care. Furthermore, governments are increasingly investing in healthcare technologies, facilitating a conducive environment for market growth. For instance, the Japan Ministry of Health, Labour and Welfare has been actively promoting the integration of robotics in healthcare settings, highlighting the region's commitment to technological advancement and improved healthcare delivery.

Japan plays a pivotal role in the healthcare humanoid robot market, leveraging its advanced technological landscape and a significant aging demographic. The country’s unique cultural acceptance of robotics in daily life fosters a favorable environment for humanoid robot adoption in healthcare settings. With a substantial portion of its population aged 65 and over, Japan faces a pressing need for innovative solutions to support elder care. Companies like SoftBank Robotics have been at the forefront, developing humanoid robots such as Pepper, which assist in various healthcare functions, from patient interaction to monitoring. This proactive approach not only addresses immediate healthcare challenges but also positions Japan as a leader in the development and implementation of robotic solutions, reinforcing its significance in the Asia Pacific market.

China, on the other hand, is rapidly establishing itself as a key player in the healthcare humanoid robot market, driven by its vast population and increasing healthcare demands. The government's push for technological innovation through initiatives like "Made in China 2025" emphasizes the integration of robotics in healthcare. With a burgeoning middle class and growing consumer expectations for quality healthcare, there is a marked shift towards automation in hospitals and care facilities. Companies such as Hikvision are expanding their portfolios to include healthcare robots, responding to the demand for enhanced patient care and operational efficiency. This strategic alignment with national policies and consumer preferences underscores China’s potential to significantly contribute to the regional growth of the healthcare humanoid robot market. As both Japan and China continue to innovate and adapt, the Asia Pacific region stands poised for substantial opportunities in the healthcare humanoid robot sector.

Europe Market Trends:

Europe has maintained a notable presence in the healthcare humanoid robot market, driven by a convergence of technological advancements and increasing consumer demand for automation in healthcare settings. The region benefits from a robust regulatory framework that encourages innovation while ensuring safety and efficacy, as evidenced by initiatives from the European Medicines Agency. Additionally, the rising emphasis on sustainability and efficiency in healthcare operations has led to an uptick in investments aimed at integrating humanoid robots into patient care and administrative tasks. Notably, recent collaborations between companies like SoftBank Robotics and various European healthcare providers underline the region's commitment to enhancing patient engagement through robotic solutions. Looking ahead, Europe presents significant opportunities for growth, particularly as digital transformation accelerates and healthcare systems seek to address labor shortages and improve service delivery.

Germany plays a pivotal role in the healthcare humanoid robot market, characterized by its strong emphasis on research and development. The country is witnessing a surge in demand for humanoid robots that assist with elder care, driven by its aging population and cultural attitudes towards technology in caregiving. For instance, the German Federal Ministry of Education and Research has funded projects aimed at developing robotic systems that enhance the quality of life for seniors, aligning with societal needs and regulatory support. This strategic focus on innovation positions Germany as a leader in the European market, with potential for widespread adoption of humanoid robots in various healthcare applications.

France is also a significant player in the healthcare humanoid robot market, bolstered by a favorable regulatory environment and a growing interest in AI-driven healthcare solutions. The French government has initiated programs to integrate robotics into healthcare, exemplified by the "HealthTech Innovation" initiative, which aims to foster technological integration in hospitals. This initiative, coupled with a culturally receptive attitude towards healthcare innovation, is driving the adoption of humanoid robots in clinical settings. As France continues to invest in healthcare technology, it reinforces its role as a key contributor to the region's overall growth in the healthcare humanoid robot market, presenting ample opportunities for investors and stakeholders.

Parameter North America Asia Pacific Europe Latin America MEA
Innovation Hub i Scale Nascent Developing Advanced
Cost-Sensitive Region i Scale Low Medium High
Regulatory Environment i Scale Restrictive Neutral Supportive
Demand Drivers i Scale Weak Moderate Strong
Development Stage i Scale Emerging Developing Developed
Adoption Rate i Scale Low Medium High
New Entrants / Startups i Scale Sparse Moderate Dense
Macro Indicators i Scale Weak Stable Strong
COUNTRY INSIGHTS

Key Country Insights

United States 🇺🇸

Clinical Automation Support

The U.S. is accelerating healthcare humanoid robot adoption to assist with patient engagement, hospital logistics, and routine clinical workflows. Healthcare providers are evaluating systems that integrate artificial intelligence, remote monitoring, and workforce support capabilities.

Germany 🇩🇪

Assisted Care Integration

Germany is introducing healthcare humanoid robots into hospitals and eldercare facilities to complement healthcare professionals in repetitive and non-clinical tasks. Market priorities include dependable human-machine interaction, regulatory compliance, and seamless integration with digital healthcare systems.

Japan 🇯🇵

Aging Care Innovation

Japan is advancing healthcare humanoid robots to address increasing care demands associated with an aging population. Development efforts focus on patient companionship, rehabilitation assistance, and workflow automation while maintaining safe interaction in healthcare environments.

South Korea 🇰🇷

AI Care Deployment

South Korea is expanding healthcare humanoid robot applications through investments in artificial intelligence and smart hospital technologies. Healthcare organizations are emphasizing robots that improve patient services, operational efficiency, and collaboration with medical staff.

France 🇫🇷

Patient Support Technologies

France is evaluating healthcare humanoid robots for rehabilitation centers and healthcare institutions seeking enhanced patient engagement. Commercial interest is directed toward intuitive interfaces, clinical safety standards, and solutions that support caregivers without replacing human interaction.

Italy 🇮🇹

Rehabilitation Assistance Focus

Italy is adopting healthcare humanoid robots for rehabilitation, assisted living, and hospital support services where workforce efficiency is increasingly important. The market emphasizes practical deployment, patient acceptance, and compatibility with existing healthcare delivery models.

SEGMENT ANALYSIS

Segment Leadership and Growth Trends

Healthcare Humanoid Robot Market Share (%), Component, 2025

Hardware
Software

Go beyond the chart, access full insights & data tables

Request Free Sample Report

Analysis by Component

The healthcare humanoid robot market for components is led by hardware, which held a commanding 67.9% share in 2025. This dominance can be attributed to the essential physical components required for mobility and interaction in care settings, which are critical for enhancing patient engagement and operational efficiency. As healthcare providers increasingly prioritize the integration of technology to improve patient outcomes, the demand for advanced hardware solutions is on the rise. Established players like SoftBank Robotics have demonstrated the effectiveness of their humanoid robots in various healthcare environments, showcasing the importance of robust hardware in delivering reliable care. This segment presents significant opportunities for both established firms and startups to innovate and cater to evolving healthcare needs. Given the ongoing advancements in robotics and automation, hardware is expected to remain a cornerstone of the healthcare humanoid robot market in the near to medium term.

Analysis by Application

In the healthcare humanoid robot market, the patient care and monitoring segment captured over 36.75% share in 2025, reflecting its critical role in the industry. The rising need for continuous vital sign tracking and assistance is driving this segment's growth, as healthcare facilities strive to provide high-quality care while managing increasing patient loads. Companies like Intuition Robotics have pioneered solutions that enhance the monitoring capabilities of humanoid robots, addressing both patient needs and operational challenges. The shift towards patient-centered care and the emphasis on real-time health data create strategic advantages for firms operating in this space. As healthcare systems continue to evolve toward more integrated and technology-driven models, the patient care and monitoring segment is poised to remain pivotal in the healthcare humanoid robot market.

Analysis by End-use

The healthcare humanoid robot market's end-use segment is dominated by hospitals and clinics, which represented more than 41.2% of the market share in 2025. This leadership is largely due to the high patient volume requiring automated support and monitoring, essential for enhancing operational efficiency in busy healthcare settings. Organizations such as the World Health Organization have highlighted the importance of automation in improving patient care delivery, reinforcing the need for humanoid robots in hospitals. The competitive landscape is evolving as healthcare providers seek to adopt innovative solutions that address workforce shortages and improve patient outcomes. This segment offers substantial opportunities for established companies and new entrants to develop tailored solutions that meet the specific needs of healthcare facilities. With ongoing advancements in healthcare technology and increasing demands for automation, the hospital and clinic segment is expected to maintain its significance in the healthcare humanoid robot market.

Segment Sub-Segment Largest Segment Fastest Growing
Component Hardware, Software
Application Companionship, Rehabilitation, Patient care and monitoring, Other applications
End-use Hospitals & clinics, Rehabilitation centers, Home healthcare, Other end-users
Competitive Landscape

Competitive Landscape and Market Positioning

Key players in the healthcare humanoid robot market include SoftBank Robotics, Hanson Robotics, UBTech, Toyota, Engineered Arts, PAL Robotics, Boston Dynamics, Kawada Robotics, Agility Robotics, and Promobot. These companies are at the forefront of innovation, each contributing unique capabilities and technologies that enhance the functionality of humanoid robots in healthcare settings. For instance, SoftBank Robotics has gained significant recognition for its interactive robots that assist in patient engagement, while Hanson Robotics is known for its highly expressive humanoid robots that can facilitate emotional connections with patients. Similarly, UBTech and Toyota are leveraging their expertise in robotics and automation to develop solutions that streamline healthcare operations, making them influential players in this evolving market landscape.

The competitive environment in the healthcare humanoid robot market is characterized by a dynamic interplay of strategic initiatives among the leading players. Companies are increasingly engaging in collaborative efforts to enhance their technological offerings and expand their market reach. For instance, partnerships between robotics firms and healthcare providers are fostering innovation in robotic applications, leading to the development of advanced solutions tailored to specific healthcare needs. Additionally, several key players are investing in research and development to pioneer next-generation humanoid robots that can perform complex tasks, thereby enhancing their competitive positioning. The ongoing focus on improving user experience and operational efficiency is shaping the competitive landscape, driving companies to innovate continually.

Strategic / Actionable Recommendations for Regional Players

In North America, fostering collaborations with leading healthcare institutions could enhance innovation and application development in humanoid robotics. By aligning with hospitals and research organizations, companies can gain insights into real-world challenges, enabling them to tailor their solutions more effectively.

In the Asia Pacific region, leveraging advancements in artificial intelligence and machine learning can significantly enhance the capabilities of humanoid robots. By integrating these emerging technologies, market players can improve the adaptability and functionality of their robots, catering to the unique needs of diverse healthcare settings.

In Europe, focusing on high-growth sub-segments such as elderly care and rehabilitation can present lucrative opportunities. By developing specialized humanoid robots that address these specific areas, companies can differentiate themselves and respond effectively to the increasing demand for innovative healthcare solutions.

Company Market Share Company Revenue Revenue CAGR (%) Product Portfolio Geographic Presence Innovation / R&D Focus Strategic Developments
No companies available.
🔒 This section is available as a standalone purchase. Buy only the data you need. Inquire Before Buying
Industry News

Industry Development/News

Company Name Date Key Development
Report Customization

Explore This Report

Click a section of the wheel — or its numbered marker — to preview the custom segmentation, custom table of contents, or related reports available for this market.

1 report.custom report.segments 2 Custom TOC 3 Related Reports

Healthcare Humanoid Robot Market — Custom Segments

Segment Sub-Segment
No segment data available.

Healthcare Humanoid Robot Market — report.custom

Custom Chapter Custom Details
No custom TOC data available.

Need a different cut of the data?

Request Custom Research
report.faq_name

What is the market valuation of healthcare humanoid robot?

As of 2026, the market size of healthcare humanoid robot is valued at USD 3.02 billion.

What is the projected value of the healthcare humanoid robot industry by 2035?

Healthcare Humanoid Robot Market size is predicted to expand from USD 2.61 billion in 2025 to USD 12.87 billion by 2035, with growth underpinned by a CAGR above 17.3% between 2026 and 2035.

Which geographical region leads the healthcare humanoid robot industry market?

North America region gained over 39.9% revenue share in 2025, due to advanced healthcare infrastructure and R&D investment.

Which geographical area is witnessing the highest growth rate in the healthcare humanoid robot sector?

Asia Pacific region will achieve over 20.2% CAGR during the forecast period, propelled by rising aging population and tech adoption.

How much is the hardware segment expected to grow in the healthcare humanoid robot industry beyond 2025?

In 2025, the hardware segment accounted for a 67.9% share of the healthcare humanoid robot market, driven by essential physical components for mobility and interaction in care settings.

What factors give patient care and monitoring segment a competitive edge in the healthcare humanoid robot sector?

The patient care and monitoring segment dominated the market with a 36.75% share in 2025, fueled by the rising need for continuous vital sign tracking and assistance.

Which is the largest sub-segment within the end-use segment for healthcare humanoid robot industry?

In 2025, the hospitals & clinics segment contributed a 41.2% share to the healthcare humanoid robot market, propelled by high patient volume requiring automated support and monitoring.

Which companies dominate the healthcare humanoid robot landscape?

Leading organizations shaping the healthcare humanoid robot market include SoftBank Robotics (Japan), Hanson Robotics (Hong Kong), UBTech (China), Toyota (Japan), Engineered Arts (UK), PAL Robotics (Spain), Boston Dynamics (USA), Kawada Robotics (Japan), Agility Robotics (USA), Promobot (Russia).
Testimonials

Our Clients

"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."

Quality Assurance Manager

"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."

R&D Manager

"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."

Senior Marketing Manager
THE RESEARCH BEHIND THIS REPORT

Our Research Team & Methodology

Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.

THIS REPORT'S RESEARCH VERTICAL

Research Team Overview

♢
This report was prepared by the Healthcare & Medical Devices Research Team at Fundamental Business Insights, a dedicated research group specializing in the global healthcare and medical technology industry. Our analysts continuously monitor advancements in medical technologies, clinical adoption trends, regulatory developments, reimbursement policies, healthcare infrastructure investments, competitive strategies, and evolving patient care requirements to deliver timely and reliable market intelligence. The research is developed using a structured methodology that combines primary discussions with healthcare stakeholders, company financial disclosures, regulatory publications, clinical literature, government healthcare databases, medical associations, and other authoritative secondary sources. Market estimates are validated through multiple research techniques, including top-down and bottom-up analysis, before undergoing an internal quality review to ensure accuracy, consistency, and methodological integrity prior to publication.

Prepared by the Healthcare & Medical Devices Research Team

10+
Industry Verticals
100+
Countries Analyzed
5–7
Days Standard
Delivery
12k+
Research Reports
Published
On-
Demand
Customized Research
Available
6
Months Analyst
Support
PDF + XLS
Report Deliverables

Trust & Compliance

☷D&B D-U-N-S
♢GDPR & CCPA Compliant
♙ISO 9001 Certified (ISO 9001:2015)
♙SSL Encryption
▭Secure Payments
✓Confidential Handling

Research Domains

10 coverage areas
Medical Devices & Equipment Diagnostic Imaging Clinical Diagnostics Digital Health & Telemedicine Patient Monitoring Systems Surgical & Minimally Invasive Technologies Healthcare IT & Data Systems Biotechnology & Life Sciences Pharmaceutical Technologies Healthcare Delivery & Services

Research Intelligence

Executive Leadership
Product & Technology Experts
Manufacturing & Operations Leaders
Procurement & Supply Chain Professionals
Sales & Commercial Executives
Channel Partners & Distribution Networks
Enterprise Buyers & End Users
Industry Consultants & Regulatory Experts

Research Workflow & Quality Assurance

📥
01

Data Collection

Verified information gathered through primary and secondary research.

🔍
02

Data Triangulation

Cross-validation using multiple independent data sources.

📈
03

Forecast Modelling

Market estimates developed using historical trends and analytical models.

👨‍💼
04

Analyst Validation

Findings reviewed by domain experts for accuracy and consistency.

📝
05

Editorial & Quality Review

Final editorial, quality, and compliance checks before publication.

✅
06

Final Publication

Released after successful completion of the internal review process.

Report Coverage

📊 Market Assessment

  • Market Size & Forecast
  • Market Segmentation
  • Regional Analysis
  • Growth Drivers & Challenges
  • Market Dynamics

🏢 Competitive Intelligence

  • Competitive Landscape
  • Company Profiles
  • Competitive Benchmarking
  • Mergers & Acquisitions
  • Market Share Analysis or Key Company Strategies

🔍 Strategic Analysis

  • Value Chain Analysis
  • Porter's Five Forces
  • PESTLE Analysis
  • Pricing Trends
  • Supply-Demand Analysis

🚀 Future Outlook

  • Technology Landscape
  • Regulatory Landscape
  • Investment & Funding Landscape
  • Emerging Opportunities
  • Future Market Outlook

Have a question about this report or need a custom scope?

Request Customization
License

Select License Type

Single User
US$ 4,250
Buy Now
Corporate User
US$ 6,150
Buy Now

Want this data scoped to your exact question?

Tell us the segments, regions, or competitors you need answered — an analyst will confirm scope before any custom work starts.

Talk to an Analyst →